Here are three updates on GI companies from the past week:
Despite a small, vocal group of shareholders opposing Takeda's now $58 billion Shire takeover, 88 percent of the company's shareholders voted to approve the transaction.
Bausch Health plans to boost its gastroenterology arm by acquiring select assets of Synergy Pharmaceuticals
Olympus Medical Systems Co. and former Olympus executive Hisao Yabe both pled guilty to failing to report adverse events related to Olympus' duodenoscopes.